Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

$2.84 Billion Drug Discovery Informatics Market 2017 by Function, Solution and End User - Global Forecast to 2022 - Research and Markets

Research and Markets
Posted on: 08 Jan 18

The "Drug Discovery Informatics Market by Function, Solution and End User - Global Forecast to 2022" report has been added to Research and Markets' offering.

The Global Drug Discovery Informatics Market is Expected to Reach USD 2.84 Billion in 2022 from USD 1.67 Billion in 2017 at a CAGR of 11.2%

Growth in the drug discovery informatics market is mainly driven by factors such as rising R&D expenditure across the globe, increasing focus on drug delivery, and the need to control drug discovery and development costs. Impending patent expiries and the growing biotechnology industry are also expected to provide a wide range of growth opportunities for players in the market. On the other hand, the scarcity of skilled professionals and the high pricing and setup cost of informatics software are both factors that are expected to limit market growth to a certain extent.

On the basis of function, the drug discovery informatics market is divided into sequencing and target data analysis, docking, molecular modeling, libraries & database preparation, and other functions. In 2017, the sequencing and target data analysis segment is expected to account for the largest share of the drug discovery informatics market. Factors such as the expansive application of informatics solutions in targeted analysis and the large amount of data generated during the drug discovery process are driving the growth of this segment.

On the basis of solution, the market is classified into software and services. In 2017, the software segment is expected to account for the largest share of the global drug discovery informatics market. The largest share of this segment is attributed to the fast and efficient management of data generated throughout the drug discovery process using discovery informatics software solutions.

By geography, North America is expected to account for the largest share of the drug discovery informatics market in 2017. Established pharmaceutical industry with the presence of leading pharmaceutical and biotechnology companies attributes to the largest share of North America. Europe is expected to account for the second-largest share of the drug discovery informatics market.

The key players operating in the drug discovery informatics market are IBM (US), Infosys (India), Schrodinger (US), PerkinElmer (US), and Thermo Fisher Scientific (US).

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Drug Discovery Informatics Market, By Function

7 Drug Discovery Informatics Market, By Solution

8 Drug Discovery Informatics Market, By End User

9 Drug Discovery Informatics Market, By Region

10 Competitive Landscape

11 Company Profiles

  • Jubilant Life Sciences
  • IBM
  • Infosys
  • Thermo Fisher Scientific
  • Perkinelmer
  • Schrdinger
  • Dassault Systmes
  • Charles River Laboratories
  • Selvita
  • Certara
  • Gvk Biosciences
  • Collaborative Drug Discovery
  • Openeye Scientific Software
  • IO Informatics
  • Novo Informatics

For more information about this report visit https://www.researchandmarkets.com/research/sh5f6n/2_84_billion?w=4

View source version on businesswire.com: http://www.businesswire.com/news/home/20180108006006/en/

Business Wire
www.businesswire.com

Last updated on: 08/01/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.